Table 2.

Main outcome measures by randomised intervention groups^*. Values are numbers (percentages) unless stated otherwise

	Clarithromycin (n=2172)	Placebo (n=2200)	Hazard ratio (95% CI)	P value
Primary outcome measure†
All cause mortality	184	159
Myocardial infarction/unstable angina	160	148
Total	344 (15.8)	307 (13.8)	1.15 (0.99 to 1.34)	0.08
Secondary outcome measure†
Cardiovascular mortality	89	70
Myocardial infarction/unstable angina	160	148
Total	249 (11.5)	218 (9.9)	1.17 (0.98 to 1.40)	0.09
Tertiary outcome measure†
Cardiovascular mortality	83	65
Myocardial infarction/unstable angina	153	144
Stroke	81	68
Peripheral vascular disease	34	26
Total	351 (16.2)	303 (13.7)	1.20 (1.02 to 1.39)	0.03

^*Based on a Cox regression model including sex, previous myocardial infarction, and age as mandatory covariates.

^†Patients censored after the first event.